Multiplex Assay Kit for Cluster Of Differentiation 8a (CD8a) ,etc. by FLIA (Flow Luminescence Immunoassay)

p32; CD8-A; Leu2; MAL; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Cluster Of Differentiation 8a (CD8a) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Cluster Of Differentiation 8a (CD8a) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Cluster Of Differentiation 8a (CD8a) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Cluster Of Differentiation 8a (CD8a) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 98-105 102
EDTA plasma(n=5) 78-95 91
heparin plasma(n=5) 86-102 99
sodium citrate plasma(n=5) 82-101 87

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cluster Of Differentiation 8a (CD8a) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cluster Of Differentiation 8a (CD8a) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cluster Of Differentiation 8a (CD8a) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-101% 86-95% 80-89% 99-105%
EDTA plasma(n=5) 90-97% 92-101% 94-105% 79-89%
heparin plasma(n=5) 85-94% 97-105% 93-103% 79-92%
sodium citrate plasma(n=5) 98-105% 93-102% 87-99% 97-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CD8a) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Taylor & Francis Influences of Hyriopsis cumingii polysaccharides on mice immunosignaling molecules and T lymphocyte differentiation 09540105.2017.1306494
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
EPB099Mu61 Eukaryotic Cluster Of Differentiation 8a (CD8a) Positive Control; Immunogen; SDS-PAGE; WB.
RPB099Mu02 Recombinant Cluster Of Differentiation 8a (CD8a) Positive Control; Immunogen; SDS-PAGE; WB.
RPB099Mu01 Recombinant Cluster Of Differentiation 8a (CD8a) Positive Control; Immunogen; SDS-PAGE; WB.
RPB099Mu03 Recombinant Cluster Of Differentiation 8a (CD8a) Positive Control; Immunogen; SDS-PAGE; WB.
PAB099Mu02 Polyclonal Antibody to Cluster Of Differentiation 8a (CD8a) WB; IHC; ICC; IP.
PAB099Mu01 Polyclonal Antibody to Cluster Of Differentiation 8a (CD8a) WB; IHC; ICC; IP.
FAB099Mu01 Anti-Cluster Of Differentiation 8a (CD8a) Polyclonal Antibody Flow cytometry.
LAB099Mu51 APC-Linked Polyclonal Antibody to Cluster Of Differentiation 8a (CD8a) WB; IHC; ICC; IF.
FAB099Mu41 PE-Linked Anti-Cluster Of Differentiation 8a (CD8a) Polyclonal Antibody Flow cytometry.
FAB099Mu51 APC-Linked Anti-Cluster Of Differentiation 8a (CD8a) Polyclonal Antibody Flow cytometry.
FAB099Mu81 FITC-Linked Anti-Cluster Of Differentiation 8a (CD8a) Polyclonal Antibody Flow cytometry.
SEB099Mu ELISA Kit for Cluster Of Differentiation 8a (CD8a) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB099Mu Multiplex Assay Kit for Cluster Of Differentiation 8a (CD8a) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
OGB099Mu02 Mouse Knockout Cluster Of Differentiation 8a (CD8a) Animal Experiments; Negative Control.